Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Buy' on Finish Line (FINL); Quarter-To-Date Comp Trends in Double-Digit
-
UPDATE: Canaccord Genuity Upgrades Tiffany & Co. (TIF) to Buy; Use Recent Dip As Entry Point
-
Canaccord Genuity Morning Coffee on SPDR Health Care E.T.F. (XLV): Good News, Bad News
-
Canaccord Genuity Morning Coffee on Apple (AAPL), Nokia (NOK) and Research In Motion (RIMM): Dialed In
-
Canaccord Genuity on Technology: Weekend Musing - M&A and IPOs
-
Canaccord Genuity reiterates a 'Buy' on Anacor Pharma (ANAC); Good Risk/Reward Going Into Ph3 Data for Tava
-
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Awaiting Approval of HIV-OTC Test
-
Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); EROS Pod On Track for Approval in Q3/12
-
Canaccord Genuity Maintains a 'Hold' on Nike (NKE); Cutting PT to $92 After Q4 Miss and Outlook
-
Canaccord Genuity Reiterates a 'Buy' on Mitel (MITL); Well Attended, Positive Presentation at Analyst Day
-
Canaccord Genuity Maintains a 'Hold' on Research In Motion (RIMM); Expect Eventual Sale of Company
-
Canaccord Genuity Downgrades Progress Energy (PGN) to Hold
-
Streetinsider.com's Hot Lunchtime Reads 06/28: (LULU) (LVS) (CMG) (ARNA) (TAHO)
-
Canaccord Genuity Morning Coffee on Chipotle Mexican Grill (CMG): Losing A Little Spice?
-
Canaccord Genuity Morning Coffee on Arena Pharma. (ARNA): Does This Mean I Can Keep Eating Super-Sized Double Big Mac Meals?
-
Canaccord Genuity Morning Coffee on Apple (AAPL): iWin
-
Canaccord Genuity Reiterates a 'Buy' on AtriCure Inc. (ATRC); Strong Hybrid Results
-
Canaccord Genuity Maintains a 'Buy' on Headwaters (HW); Encouraged About Second Half Trends
-
Canaccord Genuity Earnings Preview on Research In Motion Ltd. (RIMM); Weak Trends Continue; Sale Imminent
-
Canaccord Genuity Reiterates a 'Buy' on Qualcomm (QCOM); Long-term Drivers Intact
-
Streetinsider.com's Hot Lunchtime Reads 06/27: (FB) (X) (ALU) (FSLR) (JWN) (JRCC)
-
Canaccord Genuity Downgrades Canadian Pacific Railway Limited (CP) to Hold
-
Canaccord Genuity Morning Coffee on Solar Sector: Trifecta of Negative News
-
Canaccord Genuity Morning Coffee on S&P 500: Portfolio Strategist Makes Bold Call
-
Canaccord Genuity on CleanTech Energy and Power Technologies: LED Sector Shining This Summer?
-
Canaccord Genuity on Energy, Oil & Gas E&P: Tuscaloosa Takeaways
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Catalysts in Q2 & Q3
-
Canaccord Genuity Maintains a 'Buy' on DIRECTV (DTV); Shares Look Cheap
-
Canaccord Genuity Raises PT and Estimates on SBA Communications (SBAC); Announces TowerCo Acquisition
-
Canaccord Genuity Morning Coffee on GeoEye (GEOY): From A Bird's Eye View
-
Canaccord Genuity Morning Coffee on Anheuser-Busch InBev (BUD) and Constellation Brands (STZ): Seeing Stars
-
Shares of Millennial Media (MM) Trading Over 5% Higher - Canaccord Genuity Starts Coverage At 'Buy'
-
Canaccord Genuity on U.S. Portfolio Strategy; Further Bottoming Vs. No Jump To Downside
-
Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); Highlights From Analyst Event
-
UPDATE: Canaccord Genuity Starts Millennial Media (MM) at Buy; Investors Underestimating Mobile Ad Growth
-
UPDATE: Canaccord Genuity Starts Bankrate (RATE) at Buy; Risk/Reward Attractive
-
Canaccord Genuity Reiterates a 'Buy' on Bill Barrett (BBG); Considering Further Capital Allocation to Oil-Weighted Plays
-
Streetinsider.com's Hot Lunchtime Reads 06/25: (CHK) (JPM) (ACI) (CMCSA) (NOK)
-
Notable Analyst Rating Changes 06/25: (NFLX) (NVDA) (SNDK) Upgraded; (ARNA) (RIMM) (AN) Downgraded
-
Canaccord Genuity Morning Coffee on Forest Oil (FST): Change In The Corner Office – Effective Immediately
-
Canaccord Genuity Morning Coffee on Arch Coal (ACI): A Lump of Coal Along with Your Severance
-
Canaccord Genuity Morning Coffee on iShares DJ Financial ETF (IYF): Moody's Downgrade
-
Canaccord Genuity on Life Sciences: Generic Adderall XR Approval Offers Several Cross-stock Implications
-
Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Win Now A Reality
-
Canaccord Genuity Maintains a 'Hold' on Nike (NKE); Risk/Reward Not Favorable Heading Into Q4 Earnings
-
Canaccord Genuity Maintains a 'Buy' on Finish Line (FINL); Q1 Preview: Don't Expect Surprises
-
Canaccord Genuity Maintains a 'Buy' on Acuity Brands (AYI); Quarterly Preview: Buy on Any Weakness
-
Canaccord Genuity Reiterates a 'Hold' on ResMed (RMD); CMS Policy Could Be Modestly Negative
-
Canaccord Genuity Reiterates a 'Hold' on Protalix BioTherapeutics (PLX); Modest U.S. But Strong In Israel
-
Canaccord Genuity Reiterates a 'Buy' on St. Jude Medical (STJ); Recommend Adding to Positions

